TONI SORICHETTI: Open Payments
NPI 1346390002 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,293 in 54 payments from 12 companies in 2025. Trend: 2023 $1,138 · 2024 $1,223 · 2025 $1,293
Food & beverage: $1,293
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 25 | $487 |
| Madrigal Pharmaceuticals | 13 | $324 |
| GENZYME CORPORATION | 1 | $125 |
| ABBVIE INC. | 3 | $93 |
| Phathom Pharmaceuticals, Inc. | 3 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Novo Nordisk Inc | 1 | $23 |
| Braintree Laboratories, Inc. | 1 | $22 |
Products named: TREMFYA, REZDIFFRA, DUPIXENT, VOQUEZNA, RINVOQ, EOHILIA, XIFAXAN, SKYRIZI.
Industry payments across PA — which companies pay providers there.
